Since one of the major resistance mechanisms toward these drugs involves alternative activation of the glucocorticoid receptor (GR), this finding indicates that interfering with cholesterol synthesis still presents a vital option in treatment-resistant PCa. This evidence concerns the gene NR3C1 and posterior cortical atrophy.